L0492-500, RPMI 1640 Dutch Modification w/o L-Glutamine w/ 1g/l Sodium Bicarbonate w/20mM Hepes - 500ml

L0492-500, RPMI 1640 Dutch Modification w/o L-Glutamine w/ 1g/l Sodium Bicarbonate w/20mM Hepes - 500ml

L0500-100, RPMI 1640 w/ L-Glutamine - 100ml

L0500-100, RPMI 1640 w/ L-Glutamine - 100ml

L0503-500, RPMI 1640 w/o L-Glutamine w/o Folic Acid - 500ml

188,02 RON

RPMI-1640 medium was developed by Moore and colleagues at Roswell Park Memorial Institute in 1966 for the growth of human leukemic cells in monolayer or suspension.

SKU
BW_L0503-500

RPMI-1640 medium was developed by Moore and colleagues at Roswell Park Memorial Institute in 1966 for the growth of human leukemic cells in monolayer or suspension.

RPMI-1640 medium is a multipurpose medium with many applications for a wide range of mammalian cell lines, such as the Jurkat cell line, hybridoma cells, human myeloma, mouse hybridoma, human leukocytes, and B and T lymphocytes.

Its formulation does not contain L-Glutamine and folic acid.

Shipping conditions: Room temperature or refrigerated transport
State: Liquid
Shelf life: 24 months
Storage: 2°C/+8°C
Sterility: Sterile filtered

Mai multe informatii

Mai multe informatii
Price 158,00 RON (preturile sunt fara TVA)
Description

RPMI-1640 medium was developed by Moore and colleagues at Roswell Park Memorial Institute in 1966 for the growth of human leukemic cells in monolayer or suspension.

RPMI-1640 medium is a multipurpose medium with many applications for a wide range of mammalian cell lines, such as the Jurkat cell line, hybridoma cells, human myeloma, mouse hybridoma, human leukocytes, and B and T lymphocytes.

Its formulation does not contain L-Glutamine and folic acid.

Shipping conditions: Room temperature or refrigerated transport
State: Liquid
Shelf life: 24 months
Storage: 2°C/+8°C
Sterility: Sterile filtered